Summary of TEAEs in ≥15% of patients in either arm (safety analysis set). (A) TEAEs. (B) TEAEs related to any treatment. TEAEs in panels A and B ordered by combined frequency in M+R and M+R-GemOx arms. Treatment cohorts were independent; no formal comparison was performed. ALT, alanine aminotransferase; AST, aspartate aminotransferase.